We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+7.66%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$455B
AUM Growth
+$26.6B
Cap. Flow
-$26.7B
Cap. Flow %
-5.87%
Top 10 Hldgs %
33.25%
Holding
16,292
New
1,466
Increased
6,223
Reduced
6,687
Closed
1,652

Top Buys

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$645M
2
TMUS icon
T-Mobile US
TMUS
+$640M
3
T icon
AT&T
T
+$517M
4
HUM icon
Humana
HUM
+$481M
5
BSX icon
Boston Scientific
BSX
+$400M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.24B
2
AAPL icon
Apple
AAPL
+$755M
3
META icon
Meta Platforms (Facebook)
META
+$707M
4
CAT icon
Caterpillar
CAT
+$472M
5
AMD icon
Advanced Micro Devices
AMD
+$449M

Sector Composition

Rank Sector Weight
1 Healthcare 3.33%
2 Technology 3.2%
3 Financials 2.22%
4 Industrials 2.17%
5 Consumer Discretionary 2.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DTIL icon
13601
CALL
Precision BioSciences
DTIL
$205M
$7.91K ﹤0.01%
350
-50
-13% -$1.65K
LFVN icon
13602
CALL
LifeVantage
LFVN
$82.9M
$7.9K ﹤0.01%
2,200
+1,000
+83% +$3.75K
SVVC
13603
CALL
DELISTED
Firsthand Technology Value Fund, Inc. Common Stock
SVVC
$7.88K ﹤0.01%
8,300
+6,600
+388% +$6.75K
OMIC
13604
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
$7.88K ﹤0.01%
217
+54
+33% +$3.31K
CCCC icon
13605
PUT
C4 Therapeutics
CCCC
$522M
$7.85K ﹤0.01%
2,500
-1,000
-29% -$5.89K
RPAR icon
13606
CALL
RPAR Risk Parity ETF
RPAR
$582M
$7.82K ﹤0.01%
400
+300
+300% +$5.83K
NKTR icon
13607
PUT
Nektar Therapeutics
NKTR
$2.49B
$7.8K ﹤0.01%
740
+100
+16% +$3.02K
ZINGW
13608
DELISTED
FTAC Zeus Acquisition Corp. Warrant
ZINGW
$7.8K ﹤0.01%
254,118
-344,626
-58% -$12.4K
AMRX icon
13609
PUT
Amneal Pharmaceuticals
AMRX
$6.32B
$7.78K ﹤0.01%
5,600
-9,800
-64% -$19.5K
WATT icon
13610
PUT
Energous
WATT
$86M
$7.72K ﹤0.01%
24
-22
-48% -$9.37K
HYMC icon
13611
PUT
Hycroft Mining Holding Corp
HYMC
$2.52B
$7.7K ﹤0.01%
1,780
-3,310
-65% -$16.1K
ARDS
13612
CALL
DELISTED
Aridis Pharmaceuticals Inc. Common Stock
ARDS
$7.7K ﹤0.01%
+24,500
New +$17.8K
PMVP icon
13613
PUT
PMV Pharmaceuticals
PMVP
$67.2M
$7.63K ﹤0.01%
1,600
+500
+45% +$3.52K
LODE icon
13614
Comstock
LODE
$263M
$7.63K ﹤0.01%
2,263
-2,353
-51% -$9.27K
PAYS icon
13615
PUT
Paysign
PAYS
$744M
$7.62K ﹤0.01%
2,100
-181,100
-99% -$619K
FORA
13616
PUT
DELISTED
Forian
FORA
$7.62K ﹤0.01%
+2,000
New +$6.96K
NVEE
13617
DELISTED
NV5 Global
NVEE
$7.59K ﹤0.01%
292
-17,060
-98% -$512K
SEGG
13618
CALL
Sports Entertainment Gaming Global Corp
SEGG
$8.21M
$7.59K ﹤0.01%
19
-10
-34% -$6.02K
NVAX icon
13619
Novavax
NVAX
$1.33B
$7.58K ﹤0.01%
1,094
-368,053
-100% -$3.39M
HBIO icon
13620
CALL
Harvard Bioscience
HBIO
$30.3M
$7.56K ﹤0.01%
180
+170
+1,700% +$5.04K
LYEL icon
13621
PUT
Lyell Immunopharma
LYEL
$342M
$7.55K ﹤0.01%
160
+60
+60% +$3.21K
APTO
13622
CALL
DELISTED
Aptose Biosciences, Inc.
APTO
$7.55K ﹤0.01%
26
-32
-55% -$9.29K
UE icon
13623
PUT
Urban Edge Properties
UE
$2.76B
$7.53K ﹤0.01%
500
-300
-38% -$4.52K
FINV
13624
PUT
FinVolution Group
FINV
$1.03B
$7.51K ﹤0.01%
1,800
-5,600
-76% -$28.3K
RCAT icon
13625
PUT
Red Cat Holdings
RCAT
$1.7B
$7.49K ﹤0.01%
7,200
+1,300
+22% +$1.49K

Similar funds

Ken Griffin's Q1 2023 Portfolio in Review

As of Q1 2023, Ken Griffin held 16,292 positions worth $455B, up 6.2% from $428B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Ken Griffin withdrew a net $26.7B in Q1 2023, closing 1,652 positions and reducing 6,687 holdings. Its most notable exit was Restaurant Brands International, an estimated $93.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 3.3% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.

Against the trend, Ken Griffin opened a new position in Keurig Dr Pepper worth $238M.

  • Ken Griffin's largest Q1 2023 buy was Keurig Dr Pepper: 6,751,572 shares worth $238M.
  • Ken Griffin added most to Invesco QQQ Trust in Q1 2023, an estimated $645M increase.
  • Ken Griffin's biggest Q1 2023 reduction was Tesla, cutting an estimated $1.24B.
  • Ken Griffin fully exited Restaurant Brands International in Q1 2023, selling an estimated $93.3M.
  • Ken Griffin's ten largest holdings make up 33% of its $455B portfolio in Q1 2023.
  • Ken Griffin opened 1,466 new positions and closed 1,652 in Q1 2023.
  • Ken Griffin's portfolio value rose 6.2% quarter-over-quarter to $455B.

Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.